Zyprexa appeal rejected by Supreme Court

Back to TopCommentsE-mailPrintBookmark and Share

The U.S. Supreme Court has refused to revive a bid to press a class-action suit against Eli Lilly and Co. over the marketing of Zyprexa, the company’s schizophrenia treatment.

The justices on Monday turned away an appeal by pension funds, unions and insurers that claim they spent more for the drug than it was worth. The plaintiffs say Lilly violated a federal racketeering law by making fraudulent claims about Zyprexa’s safety and effectiveness, and promoting it for non-approved uses.

The group was seeking $6.8 billion on behalf of thousands of so-called third-party payors. A federal appeals court said the case wasn’t appropriate for class-action status and told a trial judge to consider whether the plaintiffs filing the suit could press their individual claims.

Indianapolis-based Lilly in 2009 pleaded guilty to promoting Zyprexa for unapproved uses and agreed to pay $1.4 billion in criminal and civil penalties. Zyprexa is its top-selling drug, with about $5 billion in annual sales.

Zyprexa will lose patent protection in October, costing Lilly most of those sales to cheaper generic copies.


Post a comment to this story

We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
You are legally responsible for what you post and your anonymity is not guaranteed.
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
Subscribe to IBJ